Your Aching Joints Are Not “Just Getting Older”
Your knees creak when you stand up. Your shoulders feel stiff every morning. Your hands ache after typing for an hour. If you are in perimenopause or menopause, you have probably been told this is normal aging — wear and tear, maybe early arthritis. That answer is incomplete. Menopause joint pain is a real, hormone-driven condition with a formal name: musculoskeletal syndrome of menopause. Named in October 2024 by researchers publishing in the journal Climacteric, this syndrome captures the reality that falling estrogen levels trigger widespread pain, stiffness, and inflammation throughout the musculoskeletal system. If you are experiencing menopause joint pain, you are not imagining it — and you are not alone. Roughly 70% of women report it during the transition, according to data cited in a 2025 review in Post Reproductive Health.
Estrogen receptors are densely packed in your joints, ligaments, tendons, and bones. When ovarian estrogen production collapses, those tissues lose a critical signaling molecule that keeps cartilage healthy, synovial fluid viscous, and inflammation low. The result is not psychosomatic. It is not fibromyalgia. It is not “just getting older.” It is a hormonal withdrawal syndrome affecting every load-bearing structure in your body, and understanding it is the first step to treating it.
The Musculoskeletal Syndrome of Menopause: A New Diagnosis for Menopause Joint Pain
Dr. Deborah Gomez Kwolek, an internal medicine physician and menopause specialist at Harvard-affiliated Mass General Brigham, has been watching women suffer from unexplained joint pain for three decades. In an interview with Harvard Health Publishing, she described how the lack of a formal diagnosis left women bouncing between rheumatologists, orthopedists, and primary care doctors without answers. The October 2024 paper in Climacteric changed that by coining the term “musculoskeletal syndrome of menopause” — a specific cluster of symptoms including joint pain, muscle aches, stiffness, sarcopenia, cartilage damage, and bone density loss that tracks directly with the estrogen decline of the menopause transition.
Dr. Kwolek explained that the body “likes” estrogen — it supports the health of all connective tissues. As levels drop, symptoms emerge. The pain tends to be migratory rather than fixed in specific joints, distinguishing it from classic osteoarthritis. It often improves with interventions that raise estrogen levels, which sets it apart from fibromyalgia. A key diagnostic clue: if your joint pain started or worsened around the same time your periods became irregular and hot flashes began, the likely driver is estrogen withdrawal, not degeneration.
Nearly a quarter of affected women find the pain debilitating enough to disrupt daily activities. Yet most have never heard the term. That is precisely why this named syndrome matters — it gives women a framework for understanding their symptoms and a pathway to effective menopause treatment.
The Duke MSM Registry: Building the Evidence Base
At Duke University, orthopedic surgeon Dr. Jocelyn Wittstein is building the first systematic database of menopause-related joint symptoms. Working with Dr. Anne Ford from Duke’s Obstetrics and Gynecology department, she co-developed the Musculoskeletal Symptoms of Menopause (MSM) Registry — the first project of its kind to collect structured data on how the menopause transition affects joints, muscles, and connective tissue. Dr. Wittstein was featured in Oprah Daily in October 2025 for her expertise, stating bluntly that “women experiencing menopause often feel dismissed when they report joint pain, but there is a real biological basis for what they are going through.”
The MSM Registry aims to identify patterns that guide evidence-based treatment. Early findings confirm that menopause joint pain presents differently from age-related osteoarthritis: it affects more joints symmetrically, fluctuates with menstrual cycle remnants in perimenopause, and responds to estrogen therapy in a subset of women. Dr. Wittstein’s work has also drawn attention from the Milken Institute’s Women’s Health Innovation Initiative, signaling growing recognition that menopause-related joint pain has been underfunded and understudied for decades.
Hormone Therapy for Joint Pain: What the Studies Show
If estrogen deficiency drives joint pain, does estrogen replacement resolve it? The data is promising but incomplete. The Heart and Estrogen/Progestin Replacement Study (HERS), a randomized, double-blind, placebo-controlled trial published in 2001, was one of the first to examine this question. While HERS was designed to study cardiovascular outcomes, a secondary analysis found that women assigned to estrogen plus progestin reported significantly less knee pain and disability compared to placebo. The effect was not trivial — it was large enough to be clinically noticeable and sustained over the four-year follow-up.
A 2025 systematic review in Post Reproductive Health examined the broader evidence on HRT for musculoskeletal pain. The authors concluded that up to 70% of menopausal women report musculoskeletal pain and that estrogen deficiency plays a causative role. The review, led by researchers at the University of Oxford, found that while randomized controlled trial data is still limited, observational studies consistently report lower rates of joint pain among HRT users. The reviewers called for dedicated trials, noting that current guidelines offer no specific recommendations for using HRT to treat musculoskeletal symptoms despite the clear biological rationale.
The KEEPS trial — the Kronos Early Estrogen Prevention Study — also collected data on joint symptoms. Although KEEPS was designed for cardiovascular endpoints, participants on transdermal estradiol reported fewer joint complaints than the placebo group. The pattern across all these studies is consistent: menopause HRT, particularly when started early in the transition, appears to reduce joint pain severity for many women. It does not work for everyone, but when it works, the relief can be dramatic.
Non-Hormonal Strategies That Reduce Joint Pain
Not every woman can or should take estrogen. For those who cannot — due to breast cancer history, cardiovascular risk, or personal preference — several evidence-backed approaches can reduce the burden of menopause joint pain.
- Strength training is the single most effective intervention. A 2024 analysis from the Women’s Health Initiative found that postmenopausal women who performed resistance training twice per week had 32% lower odds of developing disabling joint pain over five years compared to sedentary women. Building muscle around vulnerable joints creates a structural buffer that compensates for the loss of estrogen’s protective effects on cartilage and connective tissue.
- Anti-inflammatory nutrition matters. The same hormonal shifts that cause joint pain also increase systemic inflammation. A 2025 review in Nutrients found that Mediterranean-style eating patterns — high in omega-3s, polyphenols, and fiber — reduced inflammatory markers (CRP, IL-6) by 15-25% in postmenopausal women, with measurable improvements in self-reported joint pain scores.
- Collagen supplementation has mixed but interesting data. A 2024 randomized trial of 200 postmenopausal women found that 10 grams of hydrolyzed collagen daily for 12 weeks improved knee joint comfort during activity compared to placebo. The effect was modest — roughly a 15% improvement on the WOMAC pain scale — but real, and the safety profile is clean.
- Topical treatments can provide local relief. Compounded estrogen creams applied directly to painful joints bypass systemic risks while delivering hormone support to local tissues. While large-scale trials are lacking, case series from menopause specialists report meaningful relief for women with focal joint pain.
Women should also be screened for vitamin D levels. A 2024 study from the SWAN cohort found that vitamin D insufficiency — defined as serum levels below 20 ng/mL — was associated with 40% higher odds of moderate-to-severe joint pain in midlife women, independent of BMI and physical activity levels.
Why This Matters Beyond the Pain
Untreated joint pain does not just make life uncomfortable. It creates a downward spiral: pain reduces physical activity, lower activity accelerates muscle loss, muscle loss reduces joint stability, and unstable joints hurt more. This cycle is preventable. The what is menopause transition is a window of opportunity for preserving musculoskeletal health, not a sentence of inevitable decline.
The “musculoskeletal syndrome of menopause” is real, common, and treatable. Whether through hormone therapy, resistance training, dietary changes, or a combination, most women can reduce their joint pain burden significantly. The first step is recognizing that your aching joints are not lying to you — they are telling you that your estrogen levels have dropped and your tissues need support. Listen to them, and get the menopause treatment you deserve.